These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 16828936)

  • 1. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
    Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
    Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
    Hevey M; Negley D; Pushko P; Smith J; Schmaljohn A
    Virology; 1998 Nov; 251(1):28-37. PubMed ID: 9813200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.
    Riemenschneider J; Garrison A; Geisbert J; Jahrling P; Hevey M; Negley D; Schmaljohn A; Lee J; Hart MK; Vanderzanden L; Custer D; Bray M; Ruff A; Ivins B; Bassett A; Rossi C; Schmaljohn C
    Vaccine; 2003 Sep; 21(25-26):4071-80. PubMed ID: 12922144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccines for biodefense.
    Dupuy LC; Schmaljohn CS
    Expert Rev Vaccines; 2009 Dec; 8(12):1739-54. PubMed ID: 19943766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors.
    Yu Y; Yu J; Li N; Wang S; Yu W; Sun Z
    Vaccine; 2009 Oct; 27(44):6148-53. PubMed ID: 19712769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.
    Lee JS; Pushko P; Parker MD; Dertzbaugh MT; Smith LA; Smith JF
    Infect Immun; 2001 Sep; 69(9):5709-15. PubMed ID: 11500447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.
    Velders MP; McElhiney S; Cassetti MC; Eiben GL; Higgins T; Kovacs GR; Elmishad AG; Kast WM; Smith LR
    Cancer Res; 2001 Nov; 61(21):7861-7. PubMed ID: 11691804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.
    Lee JS; Hadjipanayis AG; Welkos SL
    Infect Immun; 2003 Mar; 71(3):1491-6. PubMed ID: 12595467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC; An HJ; Yu YZ; Xu Q
    Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Guo JP; An HJ; Zhang SM; Wang S; Yu WY; Sun ZW
    Vaccine; 2013 May; 31(20):2427-32. PubMed ID: 23583890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
    Pushko P; Bray M; Ludwig GV; Parker M; Schmaljohn A; Sanchez A; Jahrling PB; Smith JF
    Vaccine; 2000 Aug; 19(1):142-53. PubMed ID: 10924796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon.
    Lee JS; Dyas BK; Nystrom SS; Lind CM; Smith JF; Ulrich RG
    J Infect Dis; 2002 Apr; 185(8):1192-6. PubMed ID: 11930333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
    Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors.
    Yu YZ; Liu S; Ma Y; Gong ZW; Wang S; Sun ZW
    Hum Vaccin Immunother; 2014; 10(7):1874-9. PubMed ID: 25424795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alphavirus replicon particles as candidate HIV vaccines.
    Davis NL; West A; Reap E; MacDonald G; Collier M; Dryga S; Maughan M; Connell M; Walker C; McGrath K; Cecil C; Ping LH; Frelinger J; Olmsted R; Keith P; Swanstrom R; Williamson C; Johnson P; Montefiori D; Johnston RE
    IUBMB Life; 2002; 53(4-5):209-11. PubMed ID: 12120997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques.
    Chen L; Ewing D; Subramanian H; Block K; Rayner J; Alterson KD; Sedegah M; Hayes C; Porter K; Raviprakash K
    J Virol; 2007 Nov; 81(21):11634-9. PubMed ID: 17715224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
    Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
    Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
    Greer CE; Zhou F; Legg HS; Tang Z; Perri S; Sloan BA; Megede JZ; Uematsu Y; Vajdy M; Polo JM
    Vaccine; 2007 Jan; 25(3):481-9. PubMed ID: 17052811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.